- Home
- ABLV vs ECOR Comparison
ABLV vs ECOR Comparison
Compare ABLV & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABLV
- ECOR
- Stock Information
- Founded
- ABLV 2015
- ECOR 2005
- Country
- ABLV China
- ECOR United States
- Employees
- ABLV N/A
- ECOR N/A
- Industry
- ABLV
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ABLV
- ECOR Health Care
- Exchange
- ABLV Nasdaq
- ECOR Nasdaq
- Market Cap
- ABLV 50.9M
- ECOR 50.1M
- IPO Year
- ABLV N/A
- ECOR 2018
- Fundamental
- Price
- ABLV $1.00
- ECOR $5.36
- Analyst Decision
- ABLV
- ECOR Strong Buy
- Analyst Count
- ABLV 0
- ECOR 2
- Target Price
- ABLV N/A
- ECOR $25.50
- AVG Volume (30 Days)
- ABLV 9.3K
- ECOR 67.6K
- Earning Date
- ABLV 04-23-2025
- ECOR 08-06-2025
- Dividend Yield
- ABLV N/A
- ECOR N/A
- EPS Growth
- ABLV N/A
- ECOR N/A
- EPS
- ABLV N/A
- ECOR N/A
- Revenue
- ABLV $128,932,647.00
- ECOR $26,458,000.00
- Revenue This Year
- ABLV N/A
- ECOR $23.21
- Revenue Next Year
- ABLV N/A
- ECOR $44.10
- P/E Ratio
- ABLV N/A
- ECOR N/A
- Revenue Growth
- ABLV N/A
- ECOR 41.54
- 52 Week Low
- ABLV $0.55
- ECOR $4.47
- 52 Week High
- ABLV $1.90
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- ABLV 41.19
- ECOR 49.17
- Support Level
- ABLV $1.02
- ECOR $5.13
- Resistance Level
- ABLV $1.13
- ECOR $5.69
- Average True Range (ATR)
- ABLV 0.10
- ECOR 0.39
- MACD
- ABLV -0.01
- ECOR 0.04
- Stochastic Oscillator
- ABLV 17.65
- ECOR 41.15
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.